Pharmaceuticals Market Research Reports

Pharmaceutical Market

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this industry. The pharmaceutical market, valued as a multi-billion dollar market, is undoubtedly the largest revenue generator for the life sciences industry.

The pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications. The largest segment, the market for cardiovascular drugs, records huge sales every year. The rising world population, rapid ageing of the same, and an increased prevalence of diseases are the major factors driving growth of this industry. The recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry, for the possibility of newer, advanced, and more sophisticated therapies and drugs. Developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals, regenerative medicine, stem cells, etc. These new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders. Technological growth in such interdisciplinary fields has opened up new arenas in drug discovery, drug delivery, and life sciences research.
Certain incurable diseases like cancer and AIDS, which are therapeutic areas of prime concern for scientists and doctors all over the world, depict immense growth potential for the pharmaceutical industry in the future. Surfacing of newer diseases and therefore, the rising requirement of newer drug delivery methods, explains the greater than before importance of research and development activities in the industry. Industry leaders now generously allocate around 20% of their turnover to R&D to allot the finest instruments and manpower for their use. This has helped them maintain a competitive edge over other players in the market. However, the high costs of R&D, shorter product life cycles, and trouble producing a ‘best-seller’ has introduced the trend of mergers, acquisitions, strategic alliances, and most importantly, outsourcing in the industry. Numerous companies have been entering into global tie-ups and collaborations pooling and utilizing their resources for R&D and new product development in almost all areas. With this ongoing and rapidly developing trend, countries have shown great interest in encouraging investments in developing R&D and manufacturing facilities by public funding and tax exemptions.

The industry, however, faces certain major challenges, one of them being the imbalance between the rate of introduction of novel drugs and that of patent expiry of the already existing brands. Rising research investments, development of better infrastructure, efficient allocation of resources, etc. are some of the measures adopted by players to cope with this problem. Stringent governmental regulation of this market in certain countries also sometimes restricts growth and causes loss of potential opportunities. However, certain regulatory measures such as patent protection for novel and blockbuster drugs helps manufacturers recover the massive investment costs incurred during the discovery, development, and commercialization of products. On the other hand, there are generic versions of drugs which are available at minimal prices as compared to patented drugs. These address the issue of affordability of drugs to the lower income groups.
Presently, the global pharmaceutical market is dominated by the United States. But huge double-digit growth rates are being observed in developing countries too, China and India being the best examples. This is mainly due to a large number of established multinational pharmaceutical companies outsourcing their research and manufacturing activities to these countries, owing to the favorable cost factor, modernized infrastructure, and a large and skilled base of scientifically knowledgeable manpower. Also, other emerging regional markets like Brazil, Russia, Germany, France, Spain, etc., continue to show tremendous growth in the pharmaceutical sector.

This section on pharmaceutical industry research consists of market research reports on its various segments like Cardiovascular drugs, Anesthesia drugs, Drug Discovery and Development, Dentistry, Dermatology, Blood and blood products, Clinical Diagnostics,  In vitro/Molecular Diagnostics, Radiology, Oncology, Dietary Supplements, Vaccines, Generics, and OTC drugs. The reports presented in this section include in-depth industry analysis involving major market players, latest market trends, new product developments, growth drivers, growth restrainers, market forecasts, and so on.

view less
RSS Sort By :
TITLE Price Buy Now More options

Spinal Cord Injury - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Pipeline Review, H2 2017, provides an overview ...

$ 2000


Kidney Fibrosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis - Pipeline Review, H2 2017, provides an overview of the...

$ 2000


Polycystic Kidney Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Pipeline Review, H2 2017, provide...

$ 2000


Neurofibromatoses Type II - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II - Pipeline Review, H2 2017, provide...

$ 2000


Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acid Sphingomyelinase De...

$ 2000


Ulcerative Colitis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2017, provides an overview ...

$ 2000


Gastroenteritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2017, provides an overview of the...

$ 2000


Eosinophilic Esophagitis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eosinophilic Esophagitis - Pipeline Review, H2 2017, provides ...

$ 2000


Enterocolitis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Enterocolitis - Pipeline Review, H2 2017, provides an overview of the Ent...

$ 2000


Vitiligo - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Pipeline Review, H2 2017, provides an overview of the Vitiligo (Der...

$ 2000


Rosacea - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Pipeline Review, H2 2017, provides an overview of the Rosacea (Dermat...

$ 2000


Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2017 Summary Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Dif...

$ 3500


20s Proteasome - Pipeline Review, H2 2017 Summary According to the recently published report '20s Proteasome - Pipeline Review, H2 2017'; 20s Proteasome pipeline Target constitutes close to 7 molecules. Out...

$ 3500


Glycoprotein 41 (gp41) - Pipeline Review, H2 2017 Summary Glycoprotein 41 (gp41) - Gp41 or glycoprotein 41 is a transmembrane protein that contains several sites within its ectodomain that are required for ...

$ 3500


P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Re...

$ 3500


"This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 20...

$ 4660


"This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 2022, wit...

$ 4660


"This report will be delivered in 2-3 business days after the order is placed." In 2016, the Asia-Pacific Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 202...

$ 4660


"This report will be delivered in 2-3 business days after the order is placed." The Global Vegetarian Softgel Capsules market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with...

$ 4960

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Using our subscription option, you get access to market research reports and industry data of Semiconductor and Electronics market as per your needs. Get the best of Semiconductor and Electronics research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: